Transmission Of DAA Resistance-Associated Substitutions May Inhibit HCV Cure Rates In MSM Living With HIV And HCV, Research Suggests
March 25, 2020
Infectious Disease Advisor (3/24, Das) reports researchers found that among MSM living with HIV who were recently diagnosed with “acquired HCV genotype 1a infection” that “the transmission of direct-acting antiviral (DAA) resistance-associated substitutio...